Cheryl Satin, Toronto

About Cheryl

Cheryl's practice focuses on mergers and acquisitions, divestitures, private equity investments, joint ventures and corporate reorganizations. She has substantial experience in negotiating and advising in connection with acquisitions and divestitures for both public and private companies, with a particular focus in the financial services, insurance and life sciences industries.

Cheryl also has extensive experience in assisting clients in the life sciences and insurance industries in connection with their commercial outsourcing arrangements. In the life sciences area, she routinely acts for manufacturers and distributors of pharmaceutical products and medical devices in connection with their product licensing, marketing, distribution, and supply arrangements. For financial institutions and insurers, she regularly advises in connection with the implementation of insurance programs and national and international reinsurance arrangements.

Cheryl is a Co-Practice Group Leader of the Corporate & Commercial group in Toronto. She has also served on the Firm's Executive Committee, Compensation Committee, Nominations Committee, and Partnership Committee.

Select Experience

Recent representative matters include acting for:

Financial Services/Insurance

Royal Bank of Canada on its C$13.5-billion acquisition of HSBC Bank of Canada
Ontario Teachers Pension Plan Board on its acquisition of HomeQ Corporation, the parent company of Home Equity Bank
Pacific Equity Partners on its C$165-million divestiture of AST Investor Services Inc. (Canada) and AST Trust Company (Canada) to the TMX Group Limited
Intact Financial Corporation on its C$1-billion acquisition of The Guarantee Company of North America and MGA Frank Cowan Company Limited
Republic Financial Holdings Limited on its acquisition of Scotiabank's Caribbean banking operations
Transamerica/Aegon on the C$600-million sale of its business in Canada to Wilton Re/CPPIB
VRG Capital in connection with its backing of a management buy-out of Jones Brown Inc. and the subsequent sale of Jones Brown to Arthur J. Gallagher & Co.
Three leading Canadian trust companies in connection with the divestitures of their corporate trust and stock transfer businesses
Intact Financial Corporation with its C$2.6-billion acquisition of the Canadian insurance businesses of AXA S.A

Life Sciences

GlaxoSmithKline Biologicals S.A. on its advanced purchase agreement with the Government of Canada for the supply of adjuvanted COVID-19 vaccines in collaboration with Sanofi
GlaxoSmithKline Biologicals S.A. on its collaboration agreement with Medicago Inc. to develop, manufacture and distribute a COVID-19 candidate vaccine
GlaxoSmithKline Inc. on its supply agreement to provide the Government of Canada with its COVID-19 monoclonal antibody therapy
Catalent Pharma Solutions Ltd., as Canadian counsel, on its purchase of all of the shares of Accucaps Industries Ltd. from Apotex Holdings Inc.
A large multinational provider of electronic and electronical products, systems and solutions on the Canadian aspects of a multi-billion dollar sale of their global medical device business
A private equity firm in connection with its acquisition and continuing consolidation of specialist dental and orthodontist practices across Canada
GlaxoSmithKline plc, as Canadian counsel, in connection with the Canadian aspects of its major three-part inter-conditional transaction with Novartis AG involving its vaccines, oncology and consumer healthcare businesses (this deal was named Matter of the Year in the 2015 GCR Awards)

Other Recent M&A

Equinix, Inc. on its C$1.04-billion acquisition of 25 data-centre facilities across Canada from BCE Inc.
Maple Leaf Foods on its acquisition of LightLife Foods
Maple Leaf Foods Inc. on the sale of its animal nutrition and Rothsay businesses

Awards & Recognition

Cheryl is recognized in:

Lexpert Special Edition: Finance and M&A 2025
The Legal 500 Canada 2025 (Corporate and M&A)
The Best Lawyers in Canada 2025 (Health Care Law, Corporate Law, Mergers and Acquisitions Law)
Chambers Canada Legal Guide – 2022–2025 (Life Sciences: Corporate/Commercial)
The Canadian Legal Lexpert Directory (2021–2025: Corporate Mid-Market; 2022, 2024–2025: Corporate Commercial Law; 2022–2025: Life Sciences & Health, Private Equity; 2021–2022, 2024–2025: Mergers & Acquisitions)
Thomson Reuters Stand-out Lawyers – Independently Rated Lawyers – 2021, 2024–2025 (As nominated by senior in-house counsel)
Lexpert Special Edition: Technology and Health Sciences 2024
The Best Lawyers in Canada 2024 (Health Care Law, Mergers and Acquisitions Law)
IFLR1000: The Guide to the World's Leading Financial and Corporate Law Firms 2023 (M&A)
The Best Lawyers in Canada – 2021–2023 (Health Care Law)
IFLR1000: The Guide to the World's Leading Financial and Corporate Law Firms – 2022 (M&A)
Chambers Canada Legal Guide – 2020–2021 (Life Sciences)
Lexology Index: Life Sciences 2016